Insuline Medical Stock Five Year Return
INSL Stock | ILS 199.00 23.00 10.36% |
Insuline Medical fundamentals help investors to digest information that contributes to Insuline Medical's financial success or failures. It also enables traders to predict the movement of Insuline Stock. The fundamental analysis module provides a way to measure Insuline Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Insuline Medical stock.
Insuline |
Insuline Medical Company Five Year Return Analysis
Insuline Medical's Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.
More About Five Year Return | All Equity Analysis
Five Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Although Five Year Returns can give a sense of overall investment potential, it is recommended to compare equity performance with similar assets for the same five year time interval. Similarly, comparing overall investment performance over the last five years with the appropriate market index is a great way to determine how this equity instrument will perform during unforeseen market fluctuations.
Competition |
According to the company disclosure, Insuline Medical has a Five Year Return of 0.0%. This indicator is about the same for the Healthcare average (which is currently at 0.0) sector and about the same as Medical Devices (which currently averages 0.0) industry. This indicator is about the same for all Israel stocks average (which is currently at 0.0).
Insuline Five Year Return Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Insuline Medical's direct or indirect competition against its Five Year Return to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Insuline Medical could also be used in its relative valuation, which is a method of valuing Insuline Medical by comparing valuation metrics of similar companies.Insuline Medical is currently under evaluation in five year return category among its peers.
Insuline Fundamentals
Price To Earning | (40.77) X | |||
Revenue | 40 K | |||
EBITDA | (6.82 M) | |||
Net Income | (7.01 M) | |||
Cash And Equivalents | 1.15 M | |||
Cash Per Share | 2.86 X | |||
Current Ratio | 0.98 X | |||
Book Value Per Share | (0.16) X | |||
Cash Flow From Operations | (7.68 M) | |||
Earnings Per Share | (30.78) X | |||
Number Of Employees | 26 | |||
Beta | 1.79 | |||
Market Capitalization | 36.33 M | |||
Total Asset | 1.58 M | |||
Retained Earnings | (158 M) | |||
Working Capital | (1000 K) | |||
Current Asset | 8 M | |||
Current Liabilities | 9 M | |||
Net Asset | 1.58 M |
About Insuline Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Insuline Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Insuline Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Insuline Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Insuline Stock
Insuline Medical financial ratios help investors to determine whether Insuline Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Insuline with respect to the benefits of owning Insuline Medical security.